@article {1983,
	title = {Assessment of Serum Irisin and Vaspin in Women with Polycystic Ovary Syndrome in Mosul City},
	journal = {Pharmacognosy Journal},
	volume = {15},
	year = {2023},
	month = {March 2023},
	pages = {212-215},
	type = {Research Article},
	chapter = {212},
	abstract = {<p class="rtejustify">Patients with {\textquotedblleft}polycystic ovary syndrome{\textquotedblright} (PCOS) may have changes in adipokine levels due to obesity rather than PCOS per se. This should be taken into account as there is a correlation between adipokine levels and BMI. The objective of the subsequent investigation was to measure serum levels of irisin and vaspin in women with PCOS. In the following study, overall, 140 sample size was selected for the evaluation. These 140 were divided into two groups in which 70 women were on the one group which was the intervention group, and 70 women were in control group. The control group of the study were the women who reportedly had regular and normal menstrual cycle. The results indicated high values of vaspin and irisin. The results of this study and previously published literature suggest that both adipocytokines are associated with high blood glucose levels and higher BMI, and finally, both values remain higher in women with PCOS. Vaspin and irisin could be considered as a biomarker for prognosis and therapy followup in patients with PCOS.</p>
},
	keywords = {FSH, Insulin, Irisin, LH, PCOS., Testosterone, Vaspin},
	doi = {10.5530/pj.2023.15.31},
	author = {Saba Khair Alddin Ibrahim}
}
